This study is a single-center, prospective randomized clinical study intended to compare and evaluate the efficacy of subjects who are treated with bone marrow aspirate concentrate (BMAC) and allograft to iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Spinal Fusion Grade at 1 Year Via CT Scan
Timeframe: Post Operative 1 Year
Change in Oswestry Disability Index (ODI) Score
Timeframe: Pre-operative, Post Operative 1 Year
Short Form Health Survey (SF-12)
Timeframe: Pre-op, Post Operative 1 Year
Change in Numeric Pain Rating Scale Score From Baseline (Pre-op) and 1 Year Post Operative
Timeframe: Pre-op, Post Operative 1 Year
Length of Stay in Hospital, Measured in Days
Timeframe: Post Operative 1 Year